ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,244Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1031

$1.23M Total Retail Price of All Prescriptions

Rank: 47 out of 1031

1,138 Patients Receiving at Least One Drug in Part D
70% Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 1,138 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

37% of this provider’s 1,138 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

12% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 3,165 1,811 399 S3 1 1
PRAVASTATIN SODIUM 1,599 1,134 302 2 10
LISINOPRIL 1,430 990 273 3 6
OMEPRAZOLE 1,075 719 185 4 2
ALPRAZOLAM 1,008 506 149 B 5 12
METFORMIN HCL 912 604 164 6 8
HYDROCHLOROTHIAZIDE 834 668 138 7 14
AMLODIPINE BESYLATE 769 601 139 8 5
LEVOTHYROXINE SODIUM 752 647 121 9 3
GABAPENTIN 641 420 139 10 11
FUROSEMIDE 630 466 136 11 7
ENALAPRIL MALEATE 598 490 89 12 66
METOPROLOL SUCCINATE 530 425 93 13 21
LOSARTAN POTASSIUM 529 427 93 14 19
CARVEDILOL 491 370 90 15 17
METOPROLOL TARTRATE 484 378 92 16 22
SIMVASTATIN 481 355 81 17 4
PANTOPRAZOLE SODIUM 470 300 82 18 24
TIZANIDINE HCL 449 198 104 19 61
TRAMADOL HCL 399 248 80 20 15
ATENOLOL 396 307 65 21 28
ATORVASTATIN CALCIUM 391 283 70 22 9
CITALOPRAM HBR 385 241 64 23 18
TAMSULOSIN HCL 373 275 76 24 33
MELOXICAM 368 242 87 25 16
GLIMEPIRIDE 356 246 55 26 40
SERTRALINE HCL 351 218 69 27 30
CLOPIDOGREL 311 230 50 28 25
PROAIR HFA 305 165 89 29 42
ESCITALOPRAM OXALATE 303 187 62 30 43
FENOFIBRATE* 286 177 52 31 55
LOVASTATIN 272 200 32 32 52
GEMFIBROZIL 264 210 45 33 112
NEXIUM 263 106 49 34 26
CLONIDINE HCL 261 196 42 35 34
ZOLPIDEM TARTRATE 244 101 40 36 20
TERAZOSIN HCL 233 188 40 37 158
DOXAZOSIN MESYLATE 215 189 37 38 115
TRAZODONE HCL 211 147 53 39 32
CLONAZEPAM 211 131 35 B 39 29
RANITIDINE HCL 204 125 46 41 44
FLUTICASONE PROPIONATE 201 120 78 42 39
HYDRALAZINE HCL 191 166 35 43 75
QUINAPRIL HCL 186 149 33 44 128
LYRICA 181 103 33 45 49
MONTELUKAST SODIUM 180 96 28 46 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 177 94 44 47 23
NAPROXEN 173 79 42 48 88
DIAZEPAM 161 67 32 B 49 74
SPIRONOLACTONE 161 90 29 49 77
WARFARIN SODIUM 155 112 31 51 27
ADVAIR DISKUS 154 88 41 52 70
POTASSIUM CHLORIDE 153 99 30 53 13
DONEPEZIL HCL 152 147* 28 54 41
ALLOPURINOL 142 115 33 55 35
BUPROPION HCL SR 135 59 35 56 172
KLOR-CON M20 132 93 24 57 73
ISOSORBIDE MONONITRATE ER 132 78 20 57 80
IBUPROFEN 126 48 31 59 99
FLUOXETINE HCL 125 25 21 60 56
POLYETHYLENE GLYCOL 3350 125 81 26 60 82
BACLOFEN 117 73 36 62 114
SPIRIVA 117 85 24 62 68
PROMETHAZINE HCL 116 21 40 R 64 67
ONDANSETRON HCL* 114 47 47 65 147
AZITHROMYCIN 113 84 101 66 46
LORAZEPAM 112 84 22 B 67 31
GLIPIZIDE 111 86 29 68 63
CYCLOBENZAPRINE HCL 110 25 31 R 69 51
DICLOFENAC SODIUM 109 58 28 70 132
ROPINIROLE HCL 109 59 23 70 76
ACETAMINOPHEN-CODEINE 102 85 21 S3 72 127
LOSARTAN-HYDROCHLOROTHIAZIDE 95 81 19 73 37
ESTRADIOL 95 72 22 R 73 109
BUSPIRONE HCL 94 60 25 75 107
COLCRYS 89 65 22 76 151
VALSARTAN-HYDROCHLOROTHIAZIDE 85 66 19 77 97
AMITRIPTYLINE HCL 83 53 20 R 78 54
QUETIAPINE FUMARATE 82 46 12 A 79 60
PIOGLITAZONE HCL 81 40 19 R 80 93
DILTIAZEM 24HR ER 80 80 16 81 145
PREDNISONE 79 55 50 82 47
LANTUS SOLOSTAR 78 45 17 83 106
ALENDRONATE SODIUM 77 72* 22 84 65
OXYBUTYNIN CHLORIDE 75 70* 21 85 134
HUMULIN 70-30 71 40 14 86 156
NIASPAN 69 64* 11 87 205
BISOPROLOL FUMARATE 67 62* 14 88 201
SYMBICORT 66 48 17 89 150
LACTULOSE 64 50 27 90 175
TEMAZEPAM 64 59* 18 B 90 83
PRIMIDONE 60 48 11 92 218
PAROXETINE HCL 60 43 17 92 64
PREMARIN 59 <11 <11 R 94 122
FINASTERIDE 59 54* 16 94 146
FENOFIBRATE* 58 53* 13 96 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 33 41 96 69
BISOPROLOL-HYDROCHLOROTHIAZIDE 56 <11 <11 98 105
GUANFACINE HCL 56 51* 14 R 98 314
TRIAMTERENE-HCTZ 56 43 11 98 57
CYMBALTA 56 <11 13 98 50
CRESTOR 56 44 14 98 36
NAMENDA 56 <11 <11 98 45
NIFEDIPINE ER 55 55 14 104 129
JANUVIA 54 <11 <11 105 72
MECLIZINE HCL 54 36 17 105 84
TRIAMCINOLONE ACETONIDE 53 48* 34 107 142
VERAPAMIL ER 52 40 12 108 96
FOSINOPRIL SODIUM 52 41 12 108 188
CELEBREX 52 <11 <11 108 89
CLOTRIMAZOLE-BETAMETHASONE 51 35 27 111 197
FAMOTIDINE* 50 37 11 112 95
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.